Presentation THT 2026 Results From The International MISSION Re-BEAT Feasibility Trial Using A Pulsatile, Soft Robotic Biventricular MCS Device That Avoids Blood Contact In Heart Failure Patients With Reduced Ejection Fraction Presenter: Stephen Wildhirt March 03, 2026
Presentation THT 2026 Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction Presenter: Edwin Ho March 03, 2026
Presentation THT 2026 Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial Presenter: Sanjiv J. Shah March 03, 2026
Presentation THT 2026 Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results Presenter: Benjamin Hibbert March 03, 2026
Presentation THT 2026 Predictors of Structural Remodeling After TAVR in Moderate Aortic Stenosis with Heart Failure with Reduced Ejection Fraction Presenter: Afek Kodesh March 03, 2026
Presentation THT 2026 Effect of Cardiac Contractility Modulation (CCM) Therapy on Reverse Remodeling in Heart Failure Patients with Left Ventricular Ejection Fraction 25-45% Presenter: Rami Kahwash March 02, 2026
Presentation THT 2026 Implant-Free Atrial Septal Shunt in a Heart Failure Patient with Reduced Ejection Fraction: A Case Report Presenter: David Niehaus March 02, 2026